Similarly, Bcl3-/- mice treated with olaparib had increased γH2AX foci compared to WT control (Supplementary Figure 5B), consistent with findings in the CRC cells (Fig. 2, Fig. 3). The gene discussed is BCL3; the disease is colorectal carcinoma.